All delays before radiotherapy risk progression of Merkel cell carcinoma
| Autor: | R Robertson, Peter C. O'Brien, Chris Wratten, G Tsang, James W. Denham, Christopher S. Hamilton |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Male
Waiting time Oncology medicine.medical_specialty Skin Neoplasms Time Factors Waiting Lists medicine.medical_treatment Malignancy Risk Assessment Internal medicine Humans Medicine Radiology Nuclear Medicine and imaging Retrospective Studies Chemotherapy Adjuvant radiotherapy Health Priorities business.industry Merkel cell carcinoma medicine.disease Carcinoma Merkel Cell Radiation therapy Waiting list Disease Progression Female Radiotherapy Adjuvant business Progressive disease |
| Zdroj: | Australasian Radiology. 48:371-375 |
| ISSN: | 1440-1673 0004-8461 |
| DOI: | 10.1111/j.0004-8461.2004.01321.x |
| Popis: | Summary Prolonged waiting times for radiotherapy have resulted in many centres assigning priorities to various patient or diagnostic groups. A high risk of progression on a waiting list is one factor that would reasonably influence the priority. The present descriptive study of 27 patients with Merkel cell carcinoma (MCC) found that a median wait of 24 days for radiotherapy is associated with a high risk of progression. Eleven (41%) of 27 patients developed progressive disease, including five (45%) of 11 patients waiting for adjuvant radiotherapy. Patients treated adjuvantly also had longer waiting times prior to their initial radiotherapy consultation (median 41 days), which may have contributed to the rate of progression. Merkel cell carcinoma is an aggressive but curable malignancy and appropriate management should include efforts to minimize all potential delays prior to the commencement of radiotherapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|